UBS Group AG - TRILLIUM THERAPEUTICS INC ownership

TRILLIUM THERAPEUTICS INC's ticker is and the CUSIP is 89620X506. A total of 137 filers reported holding TRILLIUM THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.33 and the average weighting 0.4%.

Quarter-by-quarter ownership
UBS Group AG ownership history of TRILLIUM THERAPEUTICS INC
ValueSharesWeighting
Q3 2021$24,000
-99.8%
1,355
-99.9%
0.00%
-100.0%
Q2 2021$12,279,000
-13.6%
1,265,822
-4.3%
0.00%
-20.0%
Q1 2021$14,205,000
+29.7%
1,322,584
+77.6%
0.01%
+25.0%
Q4 2020$10,953,000
+91175.0%
744,630
+91042.0%
0.00%
Q3 2020$12,000
-72.1%
817
-84.6%
0.00%
Q2 2020$43,000
-6.5%
5,300
-53.2%
0.00%
Q1 2020$46,000
+411.1%
11,313
-61.3%
0.00%
Q3 2019$9,000
+80.0%
29,208
+93.9%
0.00%
Q2 2019$5,000
-54.5%
15,065
-8.7%
0.00%
Q1 2019$11,000
+22.2%
16,506
+202.0%
0.00%
Q4 2018$9,000
-40.0%
5,466
+117.9%
0.00%
Q3 2018$15,000
+200.0%
2,509
+212.5%
0.00%
Q2 2018$5,000
+66.7%
803
+66.9%
0.00%
Q1 2018$3,000
-50.0%
481
-60.9%
0.00%
Q3 2017$6,000
-50.0%
1,230
-38.4%
0.00%
Q1 2017$12,000
+71.4%
1,997
+56.4%
0.00%
Q4 2016$7,000
+133.3%
1,277
+538.5%
0.00%
Q3 2016$3,000
+200.0%
200
+20.5%
0.00%
Q2 2016$1,000
-96.0%
166
-91.8%
0.00%
Q4 2015$25,000
+66.7%
2,014
+79.0%
0.00%
Q3 2015$15,0001,1250.00%
Other shareholders
TRILLIUM THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
VR Adviser, LLC 4,040,000$59,428,0008.74%
Fairmount Funds Management LLC 1,478,181$21,744,0007.78%
COMMODORE CAPITAL LP 852,871$12,546,0006.82%
Ghost Tree Capital, LLC 1,950,000$28,685,0006.39%
Endurant Capital Management LP 655,741$9,646,0003.48%
FRAZIER MANAGEMENT LLC 3,053,107$44,879,0003.46%
ACUTA CAPITAL PARTNERS, LLC 803,000$11,812,0003.21%
NEA Management Company, LLC 5,736,363$84,382,0002.23%
Tri Locum Partners LP 296,838$4,366,0001.59%
Avidity Partners Management LP 3,185,200$46,854,0001.52%
View complete list of TRILLIUM THERAPEUTICS INC shareholders